Meeting
2017 ASCO Annual Meeting
Antitumor activity of indenoisoquinoline inhibitors of topoisomerase 1 (TOP1) via apoptosis and autophagocytosis pathways in animal models.
Authors
Robert J. Kinders
Clinical Biomarkers Program, Laboratory of Human Toxicology and Pharmacology, Applied/Developmental Directorate, Leidos Biomedical Research, Inc., Frederick, MD
Robert J. Kinders , Angie B Dull , Deborah Wilsker , Amy LeBlanc , Christina Mazcko , Melinda G. Hollingshead , Ralph E. Parchment , James H. Doroshow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
New Targets and New Technologies
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11588)
DOI
10.1200/JCO.2017.35.15_suppl.11588
Abstract #
11588
Poster Bd #
288
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo.
First Author: Wyatt Potter
Poster
2017 Gastrointestinal Cancers Symposium
C-jun N-terminal kinase dependent autophagic cell death in cancer cells induced by Zanthoxylum fruit extract from Japanese pepper.
First Author: Toru Kono
Poster
2013 ASCO Annual Meeting
Targeting apoptosis and autophagy by a novel bcl-2 inhibitor, GX15-070, in neuroblastoma.
First Author: Herve Sartelet
Poster
2024 ASCO Breakthrough
Effect of impaired autophagic flux on breast carcinogenesis through the enhanced LC3-p62-NRF2 feedback loop.
First Author: Mehreen Aftab